Infectious Diseases News and Research

RSS

Study reveals cost-effective benefits of treating depression in low-income countries

Treating people in low-income countries for major depressive disorder can also help improve their physical health and household members' wellbeing, demonstrating that mental health treatments can be cost effective, according to a new RAND study.

30 Oct 2024

New toolkit aims to help U.S. hospitals spot deadly viral hemorrhagic fevers faster and safer

Researchers develop a laboratory toolkit to assist frontline healthcare facilities or the care of patients with suspected viral hemorrhagic fevers.

30 Oct 2024

Urgent need to shift focus from fossil fuels to health

As multiple health threats from climate change break dangerous new records, the 2024 Report of The Lancet Countdown on Health and Climate Change calls for the trillions of dollars spent funding fossil fuels to be redirected and used to drive a rapid and fair transition to a net zero greenhouse gas (GHG) economy, instead of harming the health of billions of people across the world.

30 Oct 2024

Machine learning reveals distinct clinical states in pneumonia patients

Two patients being treated for pneumonia, an infection that causes difficulty breathing due to fluid-filled sacs in the lungs, can look vastly different and have opposing outcomes. Yet doctors struggle to accurately predict patients' prognoses and determine the most effective treatments.

29 Oct 2024

Study reveals AI's potential and pitfalls in medical diagnosis

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied how well doctors used GPT-4 -; an artificial intelligence (AI) large language model system -; for diagnosing patients.

28 Oct 2024

Research identifies respiratory transmission potential of H5N1 virus

A highly pathogenic avian influenza (HPAI) H5N1 virus, isolated from the eye of a farm worker who became infected through contact with dairy cows, was lethal in mice and ferrets infected in a high-containment laboratory environment, according to a new study in Nature.

28 Oct 2024

Researchers uncover key mechanisms of CRISPR gene editing

CRISPR/Cas9 is a gene editing tool that has revolutionized biomedical research and led to the first FDA-approved CRISPR-based gene therapy.

28 Oct 2024

Study highlights importance of RSV vaccination for high-risk populations

Since their introduction last year, researchers have been monitoring the real-world impact of the new respiratory syncytial virus (RSV) vaccines.

28 Oct 2024

Diagnostic toolkit aims to improve response to Marburg virus cases

Viral hemorrhagic fevers (VHF) such as Marburg virus disease have been in the news recently, with more than 60 cases of Marburg confirmed in Rwanda.

26 Oct 2024

Study reveals resistance of Pseudomonas aeruginosa to common cleaning agents

A new study reveals widespread resistance of a major bacterial pathogen to the active ingredients in cleaning agents commonly used in hospitals and homes.

25 Oct 2024

Antibiotic for liver disease linked to emergence of antimicrobial resistant superbug

An international team of researchers has found that an antibiotic commonly prescribed for patients with liver disease, called rifaximin, has led to the global emergence of an almost untreatable form of the antimicrobial resistant superbug vancomycin-resistant enterococcus faecium (VRE), which frequently causes serious infections in hospitalized patients.

24 Oct 2024

Study links gut bacteria infection to Alzheimer's disease progression

A groundbreaking study by researchers at Florida State University's Gut Biome Lab has revealed a potential link between an infection caused by gut bacteria and the progression of Alzheimer's disease.

24 Oct 2024

Study identifies key blood stem cells in immune system aging

What keeps some immune systems youthful and effective in warding off age-related diseases? In a new paper published in Cellular & Molecular Immunology, USC Stem Cell scientist Rong Lu and her collaborators point the finger at a small subset of blood stem cells, which make an outsized contribution to maintaining either a youthful balance or an age-related imbalance of the two main types of immune cells: innate and adaptive.

24 Oct 2024

New antibody platform targets evolving viruses

Scientists at the Icahn School of Medicine at Mount Sinai, in collaboration with colleagues in the field, have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving viruses like SARS-CoV-2: their ability to mutate and evade existing vaccines and therapies.

23 Oct 2024

Maternal antibodies may hinder malaria vaccine effectiveness in infants

Maternal antibodies passed across the placenta can interfere with the response to the malaria vaccine, which would explain its lower efficacy in infants under five months of age, according to research led by the Barcelona Institute for Global Health (ISGlobal), in collaboration with seven African centers (CISM-Mozambique, IHI-Tanzania, CRUN-Burkina Faso, KHRC-Ghana, NNIMR-Ghana, CERMEL-Gabon, KEMRI-Kenya).

23 Oct 2024

Research reveals AI's potential to transform hospital reporting processes

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient hospital quality reporting while retaining high accuracy, which could lead to enhanced health care delivery.

21 Oct 2024

Emory researchers discover enzyme to combat IgG-mediated disorders

Myasthenia gravis (MG) is a chronic autoimmune disorder in which antibodies block communication between nerves and muscle, resulting in weakness of the skeletal muscles.

21 Oct 2024

Real world data highlights effectiveness of RSV vaccine

A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the RSV -- short for respiratory syncytial virus -- vaccine.

18 Oct 2024

Exclusion of indigenous voices hinders HIV progress in Latin America

Indigenous communities in Latin America say they are being excluded from the global HIV/AIDS response, leaving them without access to life-saving medicines and prevention tools.

18 Oct 2024

New consortium launched to combat Mpox outbreak in Africa

University College Dublin (UCD) is leading MpoxVax AFRIVAC, a new €1.3 million international consortium that aims to rapidly deploy technology and develop new knowledge to end the current Mpox outbreak in the Democratic Republic of Congo (DRC) and surrounding countries.

17 Oct 2024